← Back to Clinical Trials
Recruiting NCT06227572

NCT06227572 Cognition After OSA Treatment Among Native American People (CATNAP)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06227572
Status Recruiting
Phase
Sponsor Washington State University
Condition Obstructive Sleep Apnea
Study Type INTERVENTIONAL
Enrollment 140 participants
Start Date 2025-02-06
Primary Completion 2027-12-31

Eligibility & Interventions

Sex All sexes
Min Age 40 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
CATNAP MI

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 140 participants in total. It began in 2025-02-06 with a primary completion date of 2027-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This research project will develop and implement a motivational interviewing and electronic messaging intervention to address obstructive sleep apnea (OSA), positive airway pressure (PAP) adherence, and risk of Alzheimer's disease and related dementias in American Indians. The project will work with American Indian Elders, aged 50 years and older, from three Northern Plains Reservations and surrounding communities. A total of 300 American Indian elders with a confirmed OSA diagnosis and prescribed PAP therapy will be randomized to receive usual care consisting of PAP therapy alone (control condition) or usual care plus the culturally informed CATNAP MI component (intervention condition).

Eligibility Criteria

Inclusion Criteria: * Age 50 years and older * Self report American Indian or Alaskan Native * diagnosed with obstructive sleep apnea * prescribed PAP therapy and have a device * \*Ability to understand written and spoken English; and * \*Ability and willingness to follow all study protocols. Exclusion Criteria: * Living in a household with someone who is enrolled in the study * Already using PAP device at Medicaid recommended standards * Cognitive decline, unable to consent on their own

Contact & Investigator

Central Contact

Denise Dillard, PhD

✉ denise.dillard@wsu.edu

📞 206-708-8633

Frequently Asked Questions

Who can join the NCT06227572 clinical trial?

This trial is open to participants of all sexes, aged 40 Years or older, studying Obstructive Sleep Apnea. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06227572 currently recruiting?

Yes, NCT06227572 is actively recruiting participants. Contact the research team at denise.dillard@wsu.edu for enrollment information.

Where is the NCT06227572 trial being conducted?

This trial is being conducted at Eagle Butte, United States.

Who is sponsoring the NCT06227572 clinical trial?

NCT06227572 is sponsored by Washington State University. The trial plans to enroll 140 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology